510(k) device
GI Genius Module 300 (GGM300-US)
Cosmo Artificial Intelligence - Ai, Ltd. · Gastrointesinal Lesion Software Detection System (QNP, Class II) · First FDA decision Jan 12, 2024, newest May 29, 2026Colorectal cancer and polyps
Last checked: Nov 21, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
510(k) pathway
Device trials
3
Naming "GI Genius Module"
MAUDE reports
0
Brand "GI Genius Module", since 2015
PubMed studies
0
Mentioning "GI Genius Module"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing GI Genius Module 300 (GGM300-US)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
K261369 · Decided May 29, 2026 · 32 days after receipt
Device type: Gastrointesinal Lesion Software Detection System (QNP) · GI, Urology & Nephrology
2 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "GI Genius Module", any status and sponsor, newest update first.
- AI-Assisted Optical Diagnosis (CADx) for Diminutive Colorectal PolypsNot yet recruiting
Centre hospitalier de l'Université de Montréal (CHUM)Academic, hospital or other
NCT07738484 · 840 participants (planned) · Start Aug 2026 · Primary completion Aug 2029
Device: GI Genius CADx module (Medtronic) · For: Colorectal Polyps; Colorectal Adenoma; Diminutive Colorectal Polyp
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "GI Genius Module", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QNP
2 reports: 2 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "GI Genius Module"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code QNP.
- SKOUT® systemIterative Scopes, Inc. · 510(k) 2024
- CaddieOdin Medical Limited · 510(k) 2026
- Magentiq-Colo (Me-Apds)Magentiq Eye, Ltd. · 510(k) 2026
- GI Genius System 100 and GI Genius System 200Cosmo Artificial Intelligence - Ai, Ltd. · De Novo 2023
- EW10-EC02 Endoscopy Support ProgramFujifilm Corporation · 510(k) 2026
- SKOUT systemIterative Health · 510(k) 2025
- CAD - Lower GI (EC07-01)Xiamen Inno Medical Technology Co., Ltd. · 510(k) 2026
- Me-ApdsMagentiq Eye, Ltd. · 510(k) 2023
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.